- Alliance A031201: Phase III Trial of Enzalutamide (NSC #766085) vs Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
- RTOG 0815: Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer.
- SWOG 0931: Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
- SWOG 1216: Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
For more information, contact Cheryl Patz, RN, OCN, CCRC, at 360-788-8238.